| Literature DB >> 32613118 |
Al Rey Villagracia1, Hui Lin Ong2,3, Faith Marie Lagua4, Glenn Alea4.
Abstract
Conventional drugs used to treat Tuberculosis (TB) are becoming ineffective due to the occurrence of multiple drug resistant strains of tuberculosis (TB). This has made the TB disease a a serious global health dilemma. Hence, there is desperate necessity for the advancement of new drugs. In this work, the chemical reactivity and bioactivity of several analogs ofpyrazinamide (PZA) were investigated. PZA is one of the first-line of drugs used to treat tuberculosis and is a key contributor to shortening the treatment time for the disease. Chemical reactivity descriptors of pyrazinamide (PZA) and its analogs of acetylsalicyclic acid and salicyclic acid were investigated using conceptual density functional theory in water as a solvent at the MN12SX/Def2TZVP level of theory. Results have shown that all PZA analogs have improved their global and local reactivity indeces as compared to pyrazinamide based on its electronegativity, electrodonating power, electroaccepting power, eletrophilicity, global hardness and dual descriptor condensed fukui indexes. Moreover, their pKa values are slightly higher than PZA. In terms of its drug-likeness, all PZA analogs passed the Lipinski's Rule of Five criteria. Furthermore, their bioactivity scores are significantly better than pyrazinamide indicating good reaction to G-Protein Coupled Receptor (GPCR) ligands, kinase inhibitors, ion channel modulators, nuclear receptor ligands, protease inhibitors and other enzyme targets. Overall, the PZA analogs are found to be promising anti-tuberculosis drugs. Based on global and local reactivity descriptors, pKa and bioactivity scores, PZA analog of 5-n-Octanoylsalicylic acid is the most reactive among the PZA analogs tested.Entities:
Keywords: Bioactivity; Chemical reactivity; Density functional theory; Pyrazinamide; Theoretical chemistry; Tuberculosis
Year: 2020 PMID: 32613118 PMCID: PMC7322055 DOI: 10.1016/j.heliyon.2020.e04239
Source DB: PubMed Journal: Heliyon ISSN: 2405-8440
Figure 1Pyrazinamide and its analogs.
Figure 2Ground state structures with their HOMO-LUMO orbital isosurface (isovalue: 0.02), energies and (λmax).
Figure 3Fukui Function surfaces (isovalue: 0.02), left side is (nucleophilic Fukui), right is (electrophilic Fukui). All values of Δfk are multiplied by 100 for comparison purposes with a minimum absolute value of 5.
Figure 4Global reactivity descriptors aof pyrazinamide and PZA analogs of salicylic and acetylsalicylic acids.
Figure 5Global reactivity descriptors and pKa of pyrazinamide and PZA analogs of salicylic and acetylsalicylic acids.
Molecular properties.
| Property | PZA | SAL-5a | SAL-5b | SAL-6a | SAL-6b |
|---|---|---|---|---|---|
| LogP | -0.71 | 4.54 | 2.52 | 4.10 | 2.08 |
| Topological Polar Surface Area | 68.88 | 124.77 | 124.77 | 130.85 | 130.85 |
| Molecular weight | 123.11 | 384.44 | 328.33 | 426.47 | 370.37 |
| Lipinksi's Rule Violations | 0 | 0 | 0 | 0 | 0 |
| Rotatable Bonds | 1 | 10 | 6 | 12 | 8 |
| Volume | 106.00 | 354.18 | 286.97 | 390.69 | 323.48 |
Figure 6Bioactivity properties of PZA and its analogs.